iCAD Inc. (ICAD)
2.12
-0.02 (-0.93%)
At close: Mar 28, 2025, 3:59 PM
2.14
0.94%
After-hours: Mar 28, 2025, 04:05 PM EDT
-0.93% (1D)
| Bid | 2 |
| Market Cap | 56.26M |
| Revenue (ttm) | 19.07M |
| Net Income (ttm) | -3.42M |
| EPS (ttm) | -0.21 |
| PE Ratio (ttm) | -10.1 |
| Forward PE | -15.45 |
| Analyst | n/a |
| Ask | 2.2 |
| Volume | 201,654 |
| Avg. Volume (20D) | 465,783 |
| Open | 2.12 |
| Previous Close | 2.14 |
| Day's Range | 2.03 - 2.16 |
| 52-Week Range | 1.18 - 3.78 |
| Beta | 1.96 |
About ICAD
iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, and image storage and review systems; SecondLook, a machine learning-based cancer detection algorithm tha...
Industry Medical - Devices
Sector Healthcare
IPO Date Dec 13, 1984
Employees 67
Stock Exchange NASDAQ
Ticker Symbol ICAD
Website https://www.icadmed.com
Earnings Surprise
iCAD has released their quartely earnings
on Mar 19, 2025:
Next Earnings Release
iCAD Inc. is scheduled to release its earnings on May 14, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
+17.77%
Icad shares are trading higher after the company p...
Unlock content with
Pro Subscription
4 months ago
+9.49%
iCAD shares are trading higher after the company announced it will present its next-generation AI solutions and a second-read AI partnership with Cascaid Health at the RSNA 2024 Annual Meeting.
